News from NYU Langone Health
The World Health Organisation Addresses Hantavirus Concerns
FOX 5 Health News
Purvi S. Parikh, MD, allergist and immunologist at NYU Langone Health and clinical assistant professor at the Departments of Medicine and Pediatrics at NYU Grossman School of Medicine, addressed concerns about a recent hantavirus outbreak on a cruise ship. She explained that hantavirus is very different from COVID-19, as it is primarily transmitted from mice and has very little human-to-human spread. However, she noted that the specific "Andes strain" involved in the cruise ship outbreak can be transmitted between people, which is a concern given the three deaths and other critical cases. Dr. Parikh emphasized that while the virus can be deadly, the risk of a full-blown pandemic is low because it is not as contagious as common respiratory viruses, and cruise ships represent a unique environment for rapid spread due to close quarters.
5/07/2026
Infectious disease expert breaks down what to know about Hantavirus
Spectrum News NY1
Following a Hantavirus outbreak on a cruise ship in the Atlantic that has left three people dead, health officials are addressing public health concerns. The World Health Organization confirmed eight passengers have fallen ill, with five confirmed cases of the 'Andes' strain, which can spread between people. Despite this, the WHO states the risk to the public is low. Madeline A. DiLorenzo, MD, an infectious disease physician at NYU Langone Infectious Disease Associates, clinical assistant professor at NYU Grossman School of Medicine clinical coordinator of Infectious Diseases Operations and associate hospital epidemiologist at NYU Langone Hospital - Tisch, commented on the virus and associated health concerns.
5/07/2026
No, Ivermectin Is Not Proven To Treat Hantavirus
Forbes
Public health experts are warning against viral claims that the anti-parasitic drug ivermectin can treat hantavirus, following a deadly outbreak on a cruise ship. The claims, amplified by figures like Dr. Mary Talley Bowden and Rep. Marjorie Taylor Greene, have been widely refuted by the medical community. Dana Mazo, MD, an infectious disease physician at NYU Langone’s Tisch Hospital, Kimmel Pavilion, and NYU Langone Hospital—Brooklyn, told Forbes there is no data to support using ivermectin for hantavirus in humans. She warned that such "misinformation" can cause confusion and harm. While ivermectin has shown some effect on RNA viruses in lab settings, Dr. Mazo emphasized that these results have not been proven in human patients and that there has been no specific testing of ivermectin against hantavirus at all.
5/07/2026
Cardiologists Reveal 8 Sneaky Causes of High Blood Pressure
Prevention
High blood pressure is often asymptomatic, making regular screening crucial, according to Lawrence Phillips, MD, medical director of Outpatient Clinical Cardiology, FGP, director of Nuclear Cardiology Laboratory, assistant clinical director of Strategic Affairs at the Leon H. Charney Division of Cardiology, and associate fellowship program director of CARD - cardiovascular diseases. Dr. Phillips explains that high blood pressure is like 'blood punching the walls of the heart,' which can cause damage over time. He notes that while it can often be addressed with diet and lifestyle changes, several factors contribute to the condition. These include being overweight, heavy alcohol consumption, high stress levels, and obstructive sleep apnea, which is becoming more common with rising obesity rates.
Also reporting was: Aol, Yahoo Health
5/07/2026
How algorithmic value sets enhance clinical decision-making
TechTarget
A partnership between Wolters Kluwer and MCG Health is enhancing clinical decision-making by converting value sets into structured algorithms. This technology helps automate utilization management, allowing clinicians to match patient data from EHRs with evidence-based criteria to determine medical necessity. The process saves manual hours and reduces clinical review time for providers and payers. Commenting on the technology, Tania Mucci-Elliott, MD, allergist and internist as well as a clinical instructor in the Department of Medicine at NYU Grossman School of Medicine, noted that working with structured data is crucial for reducing variability and subjectivity in healthcare.
5/07/2026
ASMBS: Metabolic, Bariatric Surgery After GLP-1 Receptor Agonist Use Boosts Weight Loss
HealthDay
A study presented at the American Society for Metabolic and Bariatric Surgery annual meeting found that preoperative weight loss with medications like semaglutide does not meaningfully reduce the effectiveness of bariatric surgery. The research, led by Karan R. Chhabra, MD, surgeon and assistant professor in the Departments of Surgery and Population Health at NYU Grossman School of Medicine, analyzed data from the Epic Cosmos database. It compared patients who used GLP-1 receptor agonists before surgery to those who did not. The findings indicate that bariatric surgery continues to deliver substantial and durable weight loss in this patient population.
5/07/2026
These 40 NY hospitals earned top safety grades in new rankings
The Times Herald (Port Huron, MI)
The Leapfrog Group awarded 40 New York hospitals with top 'A' safety grades in its spring 2026 report card. Among the honorees were several NYU Langone Health facilities. NYU Langone Hospital—Long Island, NYU Langone Hospital—Brooklyn, and NYU Langone's Tisch Hospital and Helen L. and Martin S. Kimmel Pavilion all received 'A' grades. These hospitals were also recognized with a 'Straight A' designation for sustained excellence in patient safety. The report evaluated nearly 3,000 hospitals nationwide on preventable medical errors, infections, and injuries. Other local hospitals receiving 'A' grades included facilities from Northwell Health, NewYork-Presbyterian, and Mount Sinai.
Also reporting was: The Observer-Dispatch, Times Telegram
5/07/2026
Jumping in the pool and 11 other ways to boost your half marathon recovery and bounce back faster
Runner's World UK
Running a half marathon causes microtrauma to muscles, requiring recovery time for hormones to respond and rebuild tissues stronger, according to Heather Milton, MS, PCEP, CSCS, senior exercise physiologist supervisor at NYU Langone's Sports Performance Center. Milton advises that refueling with carbohydrates and protein within two hours of finishing is crucial for muscle repair. She also notes that many half marathon runners feel good the next day because they are often better prepared for the race and recovery compared to marathoners. Continuing light movement like walking and stretching post-race is recommended to enhance blood flow and reduce inflammation.
5/07/2026
Cancer Diagnostics Startup Imagenomix Raises $3.2M in Seed Funding
GenomeWeb
Imagenomix, a cancer diagnostics spinout of NYU Langone Health, has raised $3.2 million in seed funding. The investment round was led by Modi Ventures and included the NYU Langone Venture Fund and NYU Innovation Venture Fund. Imagenomix is developing a patent-protected AI technology platform that identifies genetic alterations of cancer directly from standard histopathology images. The company will use the funds to initiate a clinical trial for its platform in breast cancer and to further develop and launch its lung cancer classifier commercially later this year.
5/07/2026
How serious is OG Anunoby’s hamstring strain? | The Injury Report
New York Post
Following Knicks player OG Anunoby's leg injury during a Game 2 win, Andrew S. Bi, MD, a sports orthopedic surgeon with NYU Langone Health, and assistant professor in the Department of Orthopedic Surgery at NYU Grossman School of Medicine, commented on the severity of the hamstring strain. Dr. Bi discussed the probability of Anunoby missing time during the team's playoff run, providing expert analysis on the potential impact of the injury on the player's availability.
5/07/2026
Pancreatic cancer drug extends survival 8.5 months: Study
Becker's Hospital Review
A study in The New England Journal of Medicine found that the drug daraxonrasib extended progression-free survival for pancreatic cancer patients by a median of 8.5 months. The research involved 15 cancer centers, including NYU Langone Health. The trial included patients with stage 4 pancreatic cancer who had previously received chemotherapy. The median overall survival was 13.1 months, and 35% of patients responded to the drug. The FDA has granted expanded access to daraxonrasib, and a phase 3 trial is now underway.
5/07/2026
DNA errors uncovered that enable tumor survival
SCIENMAG
Researchers at NYU Langone Health have discovered how cancer cells with abnormal chromosome numbers survive treatments. The study, published in *Molecular Cell*, found that these aneuploid cells have 50 to 60 percent less PARP1 protein, which prevents cell death when faced with oxidative DNA damage. The team, which included scientists from NYU Langone Health's Institute for Systems Genetics and Perlmutter Cancer Center, identified that lysosomal stress activates a factor that suppresses the PARP1 gene. Senior author Teresa Davoli, PhD, associate professor in the Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine, noted the findings open new therapeutic possibilities.
Also reporting was: Medical Xpress
5/07/2026
Pain Relief: Home Remedies and OTC Medications
World Today News
An overview of canker sore treatments highlights a tiered approach, from topical anesthetics to prescription steroids. The article discusses the efficacy of various over-the-counter options and natural remedies like honey and clove oil. It notes that emerging research is exploring the oral microbiome's role in prevention. A 2026 Phase I trial at NYU Langone Health is testing probiotic lozenges, with early data indicating a 40% reduction in recurrence rates after three months. The piece also outlines red flags that may signal underlying autoimmune disorders or nutritional deficiencies.
5/07/2026
New Global Validation Confirms Accuracy of Innovative Heart Disease Risk
SCIENMAG
A study led by researchers at NYU Langone Health has validated the American Heart Association's PREVENT cardiovascular risk tool for global use. The research, analyzing data from over 6.4 million people, confirmed the tool's accuracy in predicting 10- and 30-year risks for heart attack, stroke, and heart failure. Published in Nature Medicine, the study found PREVENT outperforms legacy models. Senior investigator Josef Coresh, MD, PhD, founding director of the Optimal Aging Institute, the Terry and Mel Karmazin Professor of Population Health and professor of medicine at NYU Grossman School of Medicine, emphasized the importance of the validation for physicians worldwide.
Also reporting was: Medical Xpress, MSN
5/07/2026
How Climate Change Makes Your Allergies Worse
Inside Climate News
Climate change is contributing to longer and more severe pollen seasons across the Northern Hemisphere. Neelima Tummala, MD, an otolaryngologist at NYU Langone and assistant professor in the Department of Otolaryngology-Head and Neck Surgery at NYU Grossman School of Medicine, states that her patients report annually that their allergies are the worst they have ever been. Rising temperatures and carbon dioxide pollution are worsening pollen seasons. Dr. Tummala also notes that climate-driven disasters can exacerbate mold allergies, and that people with allergies are more sensitive to other respiratory triggers like heat waves and air pollution, calling climate change a modifiable risk factor.
5/08/2026
The ‘Doping Olympics’ Are Coming
The Dispatch
An article examines the upcoming 'Enhanced Games,' a for-profit athletic competition that permits the use of performance-enhancing drugs. The event is contrasted with the traditional Olympics, highlighting higher financial payouts for athletes but also significant health risks. Commenting on the legitimacy of potential records, Arthur Caplan, PhD, The Drs. William F. and Virginia Connolly Mitty Professor of Bioethics and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine’s Department of Population Health, stated that comparing athletes using performance-enhancing drugs to those in clean sports is not a valid comparison, as they are not on the same playing field.
5/07/2026
Trump Order to Criminalize Homelessness Sparks Alarm
upenn.edu
Executive Order 14321 shifts federal policy on homelessness from a 'Housing First' approach to one that criminalizes unsheltered individuals and emphasizes involuntary treatment. Experts argue this misunderstands the primary cause, which is a lack of affordable housing. In a recent article in Psychiatric Services, co-author Arthur Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine’s Department of Population Health, wrote that the order will likely worsen the problems it aims to solve. The policy has faced legal challenges.
5/07/2026
